Logo Logo Logo Logo Logo
  • Home
  • Science
    • Scientific Advisory Board
    • Competitive Advantage
    • Patent Groups
    • Biopharma Pipeline
    • Research Partners
  • Team
  • Investors
    • Press Releases
    • SEC Filings
  • Contact
    • Sign up for News
  • Home
  • Science
    • Scientific Advisory Board
    • Competitive Advantage
    • Patent Groups
    • Biopharma Pipeline
    • Research Partners
  • Team
  • Investors
    • Press Releases
    • SEC Filings
  • Contact
    • Sign up for News

Catalent to Provide Parkinson’s Therapy Delivery Systems

28 September, 2018 in GB Sciences, Media, Press Release, Science
Catalent to Provide Parkinson’s Therapy Delivery Systems
26 September, 2018 in GB Sciences, Media, Press Release, Science
GB Sciences Granted a Recreational Production License
20 September, 2018 in GB Sciences, Media, Press Release, Science
November “Innovation in Medical Cannabis Therapies Symposium
19 September, 2018 in GB Sciences, Media, Press Release, Science
GB Sciences and University of Athens, Greece, Embark on Next-Level Drug Discovery
18 September, 2018 in GB Sciences, Media, Press Release, Science
Dr. Small-Howard to head panel at “State of Cannabis” Conference
03 September, 2018 in State of the States
A ROLL OUT FOR LOUISIANA’S MEDICAL MARIJUANA PROGRAM
03 September, 2018 in Cannabis Nurse, Guest Blogger, Medical, Science
Shopping at CBD dispensaries – Part One
23 August, 2018 in GB Sciences, Media, Press Release, Science
Nine Pharmacies to Serve Louisiana
21 August, 2018 in Breaking News, GB Sciences, Media, Press Release
Louisiana Partnership Yields Cultivation of First Cannabis Crop
15 August, 2018 in GB Sciences, Media, Press Release
First Quarter Revenue
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13

GBSciences, Inc.

Next generation cannabinoid research and development.